evenfolio

FMCG · NSE: GODREJAGRO

Godrej Agrovet

Q2 FY27 earnings and concall highlights

Price as of 16 Nov 2026
586.35−1.00%

Q2 FY27 earnings call · Guided by management

Call held 6 Nov 2026 · Read the filing on NSEFiling

19.7​%Oil extraction ratio · Oil palm · FY27Kataria · Q&A · p. 10
7​crop segmentsNumber of crop segments · Crop care · FY29-2030Kataria · Q&A · p. 8
50–55​%CDMO share of business · Astec LifeSciences · midtermKataria · Q&A · p. 8
2​%EBITDA margin addition · Oil palm · midterm, two to three, four-year periodKataria · Q&A · p. 7
M.Cap
₹11,282Cr
P/E
24.2×
1Y return
+3.41%
From 52W high
−16.0%

Highlights are read by AI from the company's filing and can contain mistakes. Check the source page linked to each line.

Share price

Results Q2 FY27, as filed · consolidated · ₹ Cr

Q2 FY27Q2 FY26YoYQ1 FY27QoQ
Revenue2,9952,567+16.7%2,855+4.9%
EBITDA200213-6.4%240-16.8%
EBITDA margin6.7%8.3%-164 bps8.4%-174 bps
PBTProfit before tax131125+4.9%169-22.4%
Net profit11593+24.4%135-14.3%
EPS (₹)5.994.81+24.5%6.99-14.3%

From the company's own results filing on NSE. Net profit is the owners' share. Growth and the dotted lines are worked out from the filed figures.

Guidance

EBITDA margin · Oil palm · long term2%Downstream business to add about 2% to oil palm EBITDA margin over 2-4 years

Oil palm: Target to end the year at last year's annual OER level

Sunil Kataria · Chief Executive Officer and Managing Director · Q&A · p. 6
“The target is really that can we make up for the three months hit and end up the year back at the overall OER of the last year level at an annualized basis.”

Oil palm: Double-digit FFB volume growth guidance kept; cyclones to have no impact

Sunil Kataria · Chief Executive Officer and Managing Director · Q&A · p. 11
“It will have no impact on our volume growth. Our guidance for a double-digit volume growth on FFB stays.”

Still chasing double-digit PBT growth for FY27, though it has become tougher

Sunil Kataria · Chief Executive Officer and Managing Director · Q&A · p. 15
“So, it's a bit of open-ended question, but intent, I am not giving up on a double-digit growth even right now. Let's see how it happens. Are we giving up on it? We think it's become tougher, but we will try to chase it.”

Oil palm: Oil palm chases healthy double-digit EBITDA CAGR this year and in mid-term

Sunil Kataria · Chief Executive Officer and Managing Director · Q&A · p. 15
“I think a healthy double-digit CAGR is what we chase, and we think we should be able to deliver over this year itself, and over the midterm also.”

More figures from the call

Oil palm · Capacity
13,000​hectaresPlantation area added · H1 FY27
“During H1, we added 13,000 hectares of plantations and inaugurated India's first integrated oil palm complex in Khammam in Telangana.”
Burjis Godrej · Chairpersonp. 4
Oil palm · Segments
28​%Revenue growth · Q2 FY27
“Oil palm revenue grew 28%, supported by higher realizations and a 14% growth in Fresh Fruit Bunch volumes as our plantations continue to mature. Segment profit increased 4%.”
Burjis Godrej · Chairpersonp. 4
Crop care · Acquisitions and new business
₹100​CrFirst-year revenue of Ashitaka · first year
“This would be the launch which in its first year would have crossed INR100 crores in revenue.”
Sunil Kataria · Chief Executive Officer and Managing Director · Q&Ap. 8
Astec LifeSciences · Order book
15​productsProducts in R&D pipeline · next two, three years
“we are having almost 15 products in pipeline in the R&D stage. So, these commercialization, small bit have started this year, and next two, three years, we will get a significant number which will be commercialized.”
Arijit Mukherjee · Chief Operating Officer · Q&Ap. 9
Oil palm · Demand
4,250–4,400​INRPalm oil price range · next couple of months
“my sense of what will happen is, it will remain in the range of INR4,300-INR4,400, maybe INR4,250-INR4,350 over the next couple of months.”
Sunil Kataria · Chief Executive Officer and Managing Director · Q&Ap. 10
Dairy · Segments
18​monthsGTM correction period · 18-month
“We have at least an 18-month-odd correction which we will have to do on the GTM revamp of the thing.”
Sunil Kataria · Chief Executive Officer and Managing Director · Q&Ap. 16

In short

  1. 01Q2 revenue was Rs 2,995 crore; EBITDA was Rs 222 crore at 7.4% margin; PAT rose 22% to Rs 103 crore.
  2. 02Management still aims for double-digit PBT growth in FY27 but says it has become tougher.
  3. 03Double-digit FFB volume growth guidance for oil palm is kept.
  4. 04Oil palm targets end-FY27 OER of about 19.7%+ after a heat-hit Q2 at about 18.9%.
  5. 05PKO derivatives plant to add about 2% to oil palm EBITDA margin over the mid-term; impact from Q4.
  6. 06Crop care and Astec hit by El Niño; a tough Rabi season expected; recovery may take a couple of years.
  7. 07No respite on milk prices expected for the next two quarters.
  8. 08Debt-to-equity about 0.8, expected to stay around that level in H2.

Capex

Oil palm: Mill, CPKO refinery and biogas plant commissioned at the complex in Q2

Burjis Godrej · Chairperson · p. 4
“We commissioned a mill at the complex along with a CPKO refinery and biogas plant during the quarter, strengthening our integrated ecosystem.”

Oil palm: PKO derivatives plant: hydrogenation and fractionation due in December; impact from Q4

Sunil Kataria · Chief Executive Officer and Managing Director · Q&A · p. 7
“The full-fledged hydrogenation and fractionation piece will come in December. There is also scale-up happening in two parts. The first part just gone into place. The second one will come in December. A meaningful impact will start coming in from, quarter four, and then scale up really in FY28.”

Order book

Astec LifeSciences: Astec: 90% of CDMO inquiries converted to R&D stage in Q2

Arijit Mukherjee · Chief Operating Officer · Q&A · p. 8
“So, 90% of the inquiries has converted to an R&D stage.”

Astec LifeSciences: About 70%-80% of CDMO products reaching R&D stage get commercialised

Sunil Kataria · Chief Executive Officer and Managing Director · Q&A · p. 9
“And we know that once a product reaches R&D stage, after that, conversion into commercialization is high, almost 70%-80% of that would get into commercialization.”

Segments

Animal nutrition: Animal nutrition Q2 revenue up 14%, segment profit up 32%

Burjis Godrej · Chairperson · p. 4
“Animal nutrition delivered another strong quarter with revenue growth of 14% and segment profit growth of 32%.”

Crop care: Crop care hit by El Niño demand weakness and poor mix; profitability declined

Burjis Godrej · Chairperson · p. 4
“Crop care was significantly impacted by the El Niño, and El Niño-led demand weakness and an unfavourable product mix. While revenue grew on a lower base, profitability declined, partly mitigated by our diversification into newer crop care segments.”

Astec LifeSciences: Astec: weak enterprise demand offset CDMO growth; EBITDA hit by lower prices and input costs

Burjis Godrej · Chairperson · p. 4
“At Astec LifeSciences, weak enterprise demand offset growth in the CDMO business. EBITDA was also impacted due to lower realizations and elevated input costs.”

Oil palm: Oil palm FFB growth close to double digit in H1

Sunil Kataria · Chief Executive Officer and Managing Director · Q&A · p. 6
“So, if you see, on a H1 basis, we are pretty close to a double-digit growth.”

Crop care, Astec: Crop care and Astec turnaround may take a couple of years

Sunil Kataria · Chief Executive Officer and Managing Director · Q&A · p. 9
“We will need to be a little patient, and it may take a couple of years in both the businesses.”

Demand

Oil palm: FMCG companies sampling PKO derivatives; orders hoped from Q4

Sunil Kataria · Chief Executive Officer and Managing Director · Q&A · p. 19
“Samples are being created with them, and we are hoping those orders will start flowing in from quarter four, the way pipeline is built.”

Oil palm: Palm oil prices may creep up by February-March

Sunil Kataria · Chief Executive Officer and Managing Director · Q&A · p. 10
“In the short term, we believe, yes, it will be range bound. Then I think it will creep up by Feb, March, is the sense on the pricing.”

Oil palm: PKO prices less volatile than CPO and expected to stay elevated

Sunil Kataria · Chief Executive Officer and Managing Director · Q&A · p. 19
“the fact is, the volatility in PKO is much lower than the one we are seeing in CPO. We expect PKO to still remain elevated.”

Oil palm: Cyclone rains may turn out to be a boon for palm trees, though not fully making up the deficit

Sunil Kataria · Chief Executive Officer and Managing Director · Q&A · p. 5
“I would say these cyclones, while not fully making up for the deficit, but may actually turn out to be pretty much of a boon.”

Oil palm: High Malaysian palm oil inventory could weigh on prices over two months

Sunil Kataria · Chief Executive Officer and Managing Director · Q&A · p. 10
“Second, which I think could impact over two months is a very high stock holding which has been declared in the Malaysian inventory.”

Margins and costs

Oil palm: Q2 OER about 18.9, below last year's Q2

Sunil Kataria · Chief Executive Officer and Managing Director · Q&A · p. 10
“We have ended up quarter two at around 18.9, which is lower than last year quarter two.”

Oil palm: OER recovered to last year's level in September and slightly ahead in October

Sunil Kataria · Chief Executive Officer and Managing Director · Q&A · p. 6
“Our September OER was pretty much close back to last year September’s OER, and October is marginally ahead of last year’s October.”

Dairy: Dairy revenue up 6%; value-added products 49% of portfolio; costs weigh on profit

Burjis Godrej · Chairperson · p. 4
“Dairy revenue grew 6%, led by calibrated pricing and growth in value-added products, which now account for 49% of the portfolio. Profitability remained affected by elevated milk procurement, packaging, and logistics costs.”

Dairy: No respite on milk prices for next two quarters; structural reset in milk pricing seen

Sunil Kataria · Chief Executive Officer and Managing Director · Q&A · p. 12
“I expect this to come back, if monsoon is good, only after two quarters, not before that. So, I think we will have to expect that next two quarters there is no respite. Then structural part, I think, will stay here.”

Godrej Foods: Foods EBITDA plus working media margin rose to 5.8% from 5.6%

Sunil Kataria · Chief Executive Officer and Managing Director · Q&A · p. 17
“last year we were 5.6%. We have moved to 5.8% this year, which is 20 basis points higher still.”

Debt and working capital

Net working capital at 21 days vs 32 days; absolute working capital Rs 655 crore

Burjis Godrej · Chairperson · p. 4
“Working capital management remains strong, with net working capital improving to 21 days from 32 days last year. Absolute working capital reduced to INR655 crores, strengthening balance sheet and returns on capital.”

Debt-to-equity about 0.8, expected to stay around that level in H2

Ravishankar · Q&A · p. 15
“Our debt-to-equity is at about 0.8, and we expect it to be pretty much in and around that level as we go through the second half as well.”

Some inventory to be consumed in H2, which should free up some cash

Ravishankar · Q&A · p. 15
“Some of that inventory will sort of get consumed as we go through H2. Therefore, as we get into the second half, which should overall free up some cash, and accordingly, we will see what are the kind of debt levels.”

Inventory raised in Q2 to benefit from prices amid inflation, lifting debt

Ravishankar · Q&A · p. 15
“we have proactively increased our inventory holding levels to take the benefit of better prices, given the inflation levels that we are seeing.”

CFO: working capital brought down from 31 to 22 days

Ravishankar · Q&A · p. 15
“In fact, we have brought it down from 31 to 22 days.”

Acquisitions and new business

Animal nutrition: Company exited the shrimp feed business

Burjis Godrej · Chairperson · p. 4
“We exited the shrimp feed business to sharpen our focus on profitable growth segments.”

Crop care: Insecticide Takai rolled out as a multi-crop product

Sunil Kataria · Chief Executive Officer and Managing Director · Q&A · p. 8
“Second is we have rolled out insecticide Takai® with the multi-crop piece.”

Godrej Foods: About 25% of foods business now from products launched in the last year

Sunil Kataria · Chief Executive Officer and Managing Director · Q&A · p. 13
“25% of our current business has started coming from the new product which we have launched in the last one year.”

Crop care: Soybean herbicide Ghassnash rolled out this month

Sunil Kataria · Chief Executive Officer and Managing Director · Q&A · p. 8
“we are rolling out now, we've just rolled out in this month, a soybean herbicide called Ghassnash®.”

Crop care: Crop care: one or two pipeline products a year; three coming this year

3​products
Sunil Kataria · Chief Executive Officer and Managing Director · Q&A · p. 8
“But as I declared earlier, our lot of pipeline products are going to come in every year, maybe one or two. Three are coming this year.”

Management

ACI Godrej Agrovet: New CEO at ACI Godrej in the last 10 months

Sunil Kataria · Chief Executive Officer and Managing Director · Q&A · p. 14
“Now, what we have done is we have had a new CEO change in the last 10 months.”

Dairy: Gaurav appointed new CEO of the dairy business

Sunil Kataria · Chief Executive Officer and Managing Director · Q&A · p. 18
“We have got Gaurav, who has come in as the new CEO for the dairy business.”

Head of sales transformation hired from Britannia and Marico

Sunil Kataria · Chief Executive Officer and Managing Director · Q&A · p. 18
“We have created a center of excellence of sales transformation, where we have hired a head of sales transformation who is coming from Britannia and Marico.”

Ravishankar is the new CFO

Sunil Kataria · Chief Executive Officer and Managing Director · p. 15
“I am pulling in Ravi, our new CFO.”

Two more sales transformation team members to join by December

Sunil Kataria · Chief Executive Officer and Managing Director · Q&A · p. 18
“By December, we will have two more members in that team which will join in below him, who will then drive the sales transformation agenda from next year onwards.”

Risks

El Niño: monsoon about 13% below normal, reservoirs at 10-year low, Rabi season uncertain

Burjis Godrej · Chairperson · p. 3
“El Niño intensified into a super event, with the monsoon ending about 13% below normal and reservoir levels at a 10-year low, creating uncertainty for the Rabi season.”

Oil palm: Ground assessment finds no damage to oil palm trees from cyclones

Sunil Kataria · Chief Executive Officer and Managing Director · Q&A · p. 11
“Our ground assessment is that there has been no damage to the trees.”

Crop care: Tough Rabi season expected as reservoir levels have crashed

Sunil Kataria · Chief Executive Officer and Managing Director · Q&A · p. 7
“I think the pieces that we have to brace for is that India is going to see a tough Rabi season because the reservoir levels have crashed.”

Crop care: Short-term pain expected in crop care

Sunil Kataria · Chief Executive Officer and Managing Director · Q&A · p. 8
“But in the short term, I think there is going to be a bit of pain, which we will have to brace for.”

Oil palm: Andhra Pradesh new fruit price order not yet out; last year's was 20.01%

Sunil Kataria · Chief Executive Officer and Managing Director · Q&A · p. 10
“The second question on the Andhra Pradesh government, yes, the last year order was 20.01%. The new order pricing has not come out as yet.”

Other

Q2 consolidated revenue at Rs 2,995 crore, led by animal nutrition, oil palm and B2C foods

Burjis Godrej · Chairperson · p. 3
“on-year to INR2,995 crores, driven by higher realizations and volume growth, led by animal nutrition, oil palm, and our B2C food segment, while our Bangladesh JV maintained strong momentum.”

Q2 EBITDA Rs 222 crore at 7.4% margin; PBT up 5% to Rs 131 crore; PAT up 22% to Rs 103 crore

Burjis Godrej · Chairperson · p. 3
“EBITDA remained stable at INR222 crores, despite significant cost inflation, with margin at 7.4%. Profit before tax grew 5% to INR131 crores, and PAT was up 22% to INR103 crores.”

Oil palm: PKO derivatives plant opened 1 September; no meaningful Q2 contribution

Sunil Kataria · Chief Executive Officer and Managing Director · Q&A · p. 6
“First of all, it got opened only on 1st of September.”

No one-off in other income; Rs 50 crore dividend received from Bangladesh JV

Ravishankar · Q&A · p. 16
“There is no one-off sitting there. The dividend of INR50 crores is from our Bangladesh JV, which has come in this quarter.”

Pet food income in other income about Rs 5 crore in the quarter

Ravishankar · Q&A · p. 16
“It is roughly about INR5 crores in the quarter.”

Sources

Management's own statements, quoted from its NSE filings. This page was read by AI and can contain mistakes: check the source pages before relying on any figure. No forecast or opinion of ours. Not investment advice.

Search

Search funds, ETFs, stocks, pages and tools